In vitro activity of synthetic tetrahydroindeno[2, 1-c]quinolines on Leishmania mexicana. Issue 6 (December 2015)

• Record Type: Journal Article
• Authors: Hernández-Chinea, Concepción; Carbajo, Erika; Sojo, Felipe; Arvelo, Francisco; Kouznetsov, Vladimir V.; Romero-Bohórquez, Arnold R.; Romero, Pedro J.
• Is Part Of: Parasitology international. Volume 64:Issue 6(2015:Dec.)
• Page Start: 479
• Page End: 483
• Publication Date: 2015-12
• Subjects: Parasitology -- Periodicals; Parasites -- Periodicals; Parasitic Diseases -- Periodicals; Parasitology -- Periodicals; Parasitologie -- Périodiques; 571.99905
• DOI: 10.1016/j.parint.2015.06.011
• Languages: English
• ISSNs: 1383-5769

Abstract

<abstract abstract-type="author" id="ab0005"> <title id="st0005">Abstract</title> <sec> <p id="sp0005">New synthetic compounds based on tetrahydroindenoquinoline structure were evaluated for their in vitro antileishmanial activities. The seven compounds assayed have antiproliferative activities against promastigotes of <italic>Leishmania mexicana</italic>. Compound <bold>1</bold> and <bold>3</bold> were the most active (IC₅₀ 1.0 μg/ml) and showed high selectivity towards the parasite. These compounds were selected to evaluate their effect on promastigote morphology and mitochondrial transmembrane potential as well as on the amastigote capability to survive into macrophages J774 cell line.</p> <p id="sp0010">Whereas compound <bold>1</bold> affected the promastigote cell cycle, compound 3 induced morphological changes and the total collapse of the mitochondrial transmembrane potential, a hallmark of apoptosis. Both compounds also affected the amastigote form of the parasite, decreasing their survival rate in J774 macrophages.</p> <p id="sp0015">Due to the greatest selectivity index, the apparent effect as apoptotic inducer and its sustained inhibition on intracellular amastigote replication, compound <bold>3</bold> is the best candidate to be tested in vivo. This compound is worth considering for the development of new antileishmanial drugs.</p> </sec> </abstract>